Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01723930
Other study ID # 5328
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 6, 2012
Last updated November 7, 2012

Study information

Verified date November 2012
Source University Hospital, Strasbourg, France
Contact Julien POTTECHER, MD
Phone 03 88 12 70 95
Email julien.pottecher@chru-strasbourg.fr
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

Get a better understanding of the pathophysiological processes of acute respiratory failure following cardiopulmonary bypass to initiate timely therapies targeted on a cell line.

Demonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient man or woman > 18 y.o.

- Patient has signed informed consent prior to the study

- Patient affiliated to a social security administration

- Patient operated on for cardiac surgery at the University Hospital of Strasbourg.

- Patient at high risk for postoperative respiratory failure defined by a SLIP score (Kor et al.) = 22 Kor:

- High-risk cardiac intervention under cardiopulmonary bypass (19 pts)

- COPD (10 pts)

- Diabetes (6 pts)

- gastroesophageal reflux (7 pts)

- Alcohol abuse (11 pts)

- Scheduled use of a pulmonary artery catheter and a left atrial catheter

Exclusion Criteria:

- Inability to obtain informed consent from the patient and / or unable to give informed patient information (difficulty understanding ...)

- Urgent surgery (<24h)

- Acute heart failure

- Patient ventilated preoperatively

- Allergy to Latex

- Persons deprived of liberty or under judicial protection

- Patient placed under guardianship

- Pregnancy

- Breastfeeding

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Acute Lung Injury
  • Acute Respiratory Distress Syndrome After Cardiac Surgery Under Cardiopulmonary Bypass
  • Respiratory Distress Syndrome, Adult
  • Respiratory Distress Syndrome, Newborn

Locations

Country Name City State
France University Hospital Strasbourg Alsace

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance Demonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass. during the surgery No